1-7 of 7
Martine J. Piccart
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: An Expert Consensus on Open Issues for Future Research

Fabio Conforti, Laura Pala, Tommaso De Pas, Emma Zattarin, Chiara Catania, Emilia Cocorocchio, Giovanna Rossi, Daniele Laszlo, Marco Colleoni, Alberto Zambelli, Gabriel N. Hortobagyi, Javier Cortes, Martine J. Piccart, Mitch Dowsett, Richard D. Gelber, Giuseppe Viale
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (6): 1093–1103.
https://doi.org/10.1158/1078-0432.CCR-23-1836
Published: 15 March 2024
View article titled, Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: An Expert Consensus on Open Issues for Future Research
Open the PDF for Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: An Expert Consensus on Open Issues for Future Research in another window
Journal Articles

Association of p27 and Cyclin D1 Expression and Benefit from Adjuvant Trastuzumab Treatment in HER2-Positive Early Breast Cancer: A TransHERA Study

Martin Filipits, Urania Dafni, Michael Gnant, Varvara Polydoropoulou, Margaret Hills, Astrid Kiermaier, Evandro de Azambuja, Denis Larsimont, Federico Rojo, Giuseppe Viale, Masakazu Toi, Nadia Harbeck, Kathleen I. Prichard, Richard D. Gelber, Phuong Dinh, Dimitrios Zardavas, Brian Leyland-Jones, Martine J. Piccart-Gebhart, Mitch Dowsett
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (13): 3079–3086.
https://doi.org/10.1158/1078-0432.CCR-17-3473
Published: 01 July 2018
View article titled, Association of p27 and Cyclin D1 Expression and Benefit from Adjuvant Trastuzumab Treatment in HER2-Positive Early Breast Cancer: A TransHERA Study
Open the PDF for Association of p27 and Cyclin D1 Expression and Benefit from Adjuvant Trastuzumab Treatment in HER2-Positive Early Breast Cancer: A TransHERA Study in another window
Includes: Supplementary data
Journal Articles

Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling

Hatem A. Azim, Jr, Stefan Michiels, Philippe L. Bedard, Sandeep K. Singhal, Carmen Criscitiello, Michail Ignatiadis, Benjamin Haibe-Kains, Martine J. Piccart, Christos Sotiriou, Sherene Loi
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (5): 1341–1351.
https://doi.org/10.1158/1078-0432.CCR-11-2599
Published: 01 March 2012
View article titled, Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling
Open the PDF for Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling in another window
Includes: Supplementary data
Journal Articles

Class III β-Tubulin Isotype Predicts Response in Advanced Breast Cancer Patients Randomly Treated Either with Single-Agent Doxorubicin or Docetaxel

Carlos M. Galmarini, Isabelle Treilleux, Fatima Cardoso, Chantal Bernard-Marty, Virginie Durbecq, David Gancberg, Marie-Christine Bissery, Marianne Paesmans, Denis Larsimont, Martine J. Piccart, Angelo Di Leo, Charles Dumontet
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (14): 4511–4516.
https://doi.org/10.1158/1078-0432.CCR-07-4741
Published: 15 July 2008
View article titled, Class III β-Tubulin Isotype Predicts Response in Advanced Breast Cancer Patients Randomly Treated Either with Single-Agent Doxorubicin or Docetaxel
Open the PDF for Class III β-Tubulin Isotype Predicts Response in Advanced Breast Cancer Patients Randomly Treated Either with Single-Agent Doxorubicin or Docetaxel in another window
Includes: Supplementary data
Journal Articles

Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series

Christine Desmedt, Fanny Piette, Sherene Loi, Yixin Wang, Françoise Lallemand, Benjamin Haibe-Kains, Giuseppe Viale, Mauro Delorenzi, Yi Zhang, Mahasti Saghatchian d'Assignies, Jonas Bergh, Rosette Lidereau, Paul Ellis, Adrian L. Harris, Jan G.M. Klijn, John A. Foekens, Fatima Cardoso, Martine J. Piccart, Marc Buyse, Christos Sotiriou, on behalf of the TRANSBIG Consortium
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (11): 3207–3214.
https://doi.org/10.1158/1078-0432.CCR-06-2765
Published: 01 June 2007
View article titled, Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series
Open the PDF for Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series in another window
Journal Articles

Polysomy 17 in HER-2/neu Status Elaboration in Breast Cancer: Effect on Daily Practice

Yan Ma, Laurence Lespagnard, Virginie Durbecq, Marianne Paesmans, Christine Desmedt, Maria Gomez-Galdon, Isabelle Veys, Fatima Cardoso, Christos Sotiriou, Angelo Di Leo, Martine J. Piccart, Denis Larsimont
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (12): 4393–4399.
https://doi.org/10.1158/1078-0432.CCR-04-2256
Published: 15 June 2005
View article titled, Polysomy 17 in HER-2/neu Status Elaboration in Breast Cancer: Effect on Daily Practice
Open the PDF for Polysomy 17 in HER-2/neu Status Elaboration in Breast Cancer: Effect on Daily Practice in another window
Journal Articles

HER-2 Amplification and Topoisomerase IIα Gene Aberrations as Predictive Markers in Node-positive Breast Cancer Patients Randomly Treated Either with an Anthracycline-based Therapy or with Cyclophosphamide, Methotrexate, and 5-Fluorouracil

Angelo Di Leo, David Gancberg, Denis Larsimont, Minna Tanner, Tero Jarvinen, Ghizlane Rouas, Stella Dolci, Jean-Yves Leroy, Marianne Paesmans, Jorma Isola, Martine J. Piccart
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (5): 1107–1116.
Published: 01 May 2002
View article titled, HER-2 Amplification and Topoisomerase IIα Gene Aberrations as Predictive Markers in Node-positive Breast Cancer Patients Randomly Treated Either with an Anthracycline-based Therapy or with Cyclophosphamide, Methotrexate, and 5-Fluorouracil
Open the PDF for HER-2 Amplification and Topoisomerase IIα Gene Aberrations as Predictive Markers in Node-positive Breast Cancer Patients Randomly Treated Either with an Anthracycline-based Therapy or with Cyclophosphamide, Methotrexate, and 5-Fluorouracil in another window